Trial Profile
Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus: A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled, Multiple Dose, Group Comparison Phase II Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2022
Price :
$35
*
At a glance
- Drugs Esketamine (Primary)
- Indications Tinnitus
- Focus Therapeutic Use
- Sponsors Altamira Therapeutics; Auris Medical
- 18 Sep 2014 New trial record